Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DTaP Vaccine”

199 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 199 results

Post-approval studies (Phase 4)Study completedNCT01629589
What this trial is testing

Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents

Who this might be right for
TetanusDiphtheriaPertussis+1 more
Sanofi Pasteur, a Sanofi Company 423
Large-scale testing (Phase 3)Study completedNCT01983540
What this trial is testing

Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination

Who this might be right for
DiphtheriaTetanusWhooping Cough+3 more
Sanofi Pasteur, a Sanofi Company 558
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06618196
What this trial is testing

Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age

Who this might be right for
DiphtheriaTetanusPertussis+3 more
LG Chem 336
Large-scale testing (Phase 3)WithdrawnNCT03128489
What this trial is testing

Evaluation of Immunogenicity and Safety of DTPa-IPV/Hib Conjugate Vaccine (Infanrix™-IPV/Hib) Administered at 6, 10 and 14 Weeks in Healthy Indian Infants

Who this might be right for
DiphtheriaAcellular PertussisHaemophilus Influenzae Type b+2 more
GlaxoSmithKline
Large-scale testing (Phase 3)Study completedNCT01738477
What this trial is testing

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Previously Boosted Young Adults

Who this might be right for
TetanusAcellular PertussisDiphtheria
GlaxoSmithKline 165
Testing effectiveness (Phase 2)Study completedNCT05116241
What this trial is testing

Immunogenicity and Safety of BPZE1 Intranasal Pertussis Vaccine in Healthy School-age Children

Who this might be right for
Bordetella Pertussis, Whooping Cough
ILiAD Biotechnologies 368
Post-approval studies (Phase 4)Study completedNCT02853929
What this trial is testing

Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery

Who this might be right for
DiphtheriaHepatitis BAcellular Pertussis+4 more
GlaxoSmithKline 551
Post-approval studies (Phase 4)Study completedNCT00635128
What this trial is testing

Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine

Who this might be right for
PoliomyelitisDiphtheriaTetanus+1 more
GlaxoSmithKline 415
Large-scale testing (Phase 3)Study completedNCT00148941
What this trial is testing

Immune Response and Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccines

Who this might be right for
TetanusAcellular PertussisDiphtheria
GlaxoSmithKline 4,209
Testing effectiveness (Phase 2)Study completedNCT04886154
What this trial is testing

A Study on the Safety, Effectiveness and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Adolescents and Adults

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 1,440
Testing effectiveness (Phase 2)Study completedNCT00133445
What this trial is testing

Pentavalent DTaP-Hep B-IPV

Who this might be right for
DiphtheriaHepatitis BPoliomyelitis+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 5
Large-scale testing (Phase 3)Study completedNCT00831753
What this trial is testing

Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Infanrix®Hexa in Healthy Peruvian Infants

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Sanofi Pasteur, a Sanofi Company 263
Large-scale testing (Phase 3)Study completedNCT00327184
What this trial is testing

Primary & Booster Study in Infants to Demonstrate Non-inferiority, Persistence & Immunogenicity of Hib-MenC Vaccine

Who this might be right for
Neisseria MeningitidisHaemophilus Influenzae Type b
GlaxoSmithKline 709
Large-scale testing (Phase 3)Study completedNCT00533507
What this trial is testing

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 8 Weeks of Age

Who this might be right for
Infections, Rotavirus
GlaxoSmithKline 230
Large-scale testing (Phase 3)Study completedNCT00467519
What this trial is testing

Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age

Who this might be right for
TetanusDiphtheriaPertussis
Sanofi Pasteur, a Sanofi Company 1,045
Large-scale testing (Phase 3)Study completedNCT01449812
What this trial is testing

Immunogenicity and Safety Study of Booster Dose of GSK Biologicals' IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine

Who this might be right for
Acellular PertussisTetanusDiphtheria+1 more
GlaxoSmithKline 831
Not applicableStudy completedNCT03142139
What this trial is testing

Does Timeliness of DTaP-IPV-Hib Vaccination Affect Development of Atopic Dermatitis Before 1 Year of Age?

Who this might be right for
Atopic Dermatitis
Bandim Health Project 1,027,559
Large-scale testing (Phase 3)Study completedNCT00508261
What this trial is testing

Co-Administration of Meningococcal Vaccine GSK134612 With Infanrix Hexa™ Versus Individual Administration of Each Vaccine

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 793
Large-scale testing (Phase 3)Study completedNCT00287092
What this trial is testing

Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants

Who this might be right for
PertussisDiphtheriaTetanus+2 more
Sanofi Pasteur, a Sanofi Company 807
Post-approval studies (Phase 4)UnknownNCT04638985
What this trial is testing

Evaluation of Immunogenicity and Safety of Combined Immunization of sIPV, DTaP and MMR

Who this might be right for
Vaccine
China National Biotec Group Company Limited 600
Load More Results